Similar articles

• [A fairer comparison between carvedilol and metoprolol is still to be done].

  Johnsson G, Aberg J. Johnsson G, et al. Lakartidningen. 2003 Oct 30;100(44):3543-4, 3544-5. Lakartidningen. 2003. PMID: 14651018 Swedish. No abstract available.
• [A randomized comparison of carvedilol and metoprolol in patients with chronic heart failure. The Carvedilol Or Metoprolol European Trial (COMET) ].

  Torp-Pedersen CT; Carvedilol Or Metoprolol European Trial. Torp-Pedersen CT, et al. Ugeskr Laeger. 2004 Aug 2;166(32):2671-4. Ugeskr Laeger. 2004. PMID: 15347171 Clinical Trial. Danish. No abstract available.
• Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).

  Di Lenarda A, Remme WJ, Charlesworth A, Cleland JG, Lutiger B, Metra M, Komajda M, Torp-Pedersen C, Scherhag A, Swedberg K, Poole-Wilson PA; COMET investors. Di Lenarda A, et al. Eur J Heart Fail. 2005 Jun;7(4):640-9. doi: 10.1016/j.ejheart.2004.09.010. Eur J Heart Fail. 2005. PMID: 15921806
• Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial.

  Kveiborg B, Major-Petersen A, Christiansen B, Torp-Pedersen C. Kveiborg B, et al. Vasc Health Risk Manag. 2007;3(1):31-7. Vasc Health Risk Manag. 2007. PMID: 17583173 Free PMC article. Review.
• [Drug therapy of chronic heart failure: when are beta receptor blockers indicated?].

  vom Dahl J, Schotten U, Sasse A. vom Dahl J, et al. Dtsch Med Wochenschr. 1999 Sep 24;124 Suppl 2:S48-53. Dtsch Med Wochenschr. 1999. PMID: 10535047 Review. German. No abstract available.